About AQUACEL™ Ag Advantage dressing
AQUACEL Ag Advantage dressing is ConvaTec’s most advanced antimicrobial dressing, and builds on the company’s 22-year history of innovation and customer collaboration with its AQUACEL dressings and the science of wound healing. At the 5th World Union of Wound Healing Societies Conference, an independent panel of Journal of Wound Care/WUWHS board members and other wound care experts named it the “Most Innovative Dressing,” an award recognizing industry achievement in developing “breakthrough technologies that have revolutionized wound care over the last four years and genuine game-changing dressings which have changed patient lives through their outcomes.”
AQUACEL Ag Advantage dressing is an enhanced Hydrofiber™ dressing with silver and strengthening fiber. AQUACEL Ag Advantage dressings combine two powerful technologies: ConvaTec’s proprietary Hydrofiber Technology and its new Advantage Technology.
As demonstrated in vitro, Hydrofber Technology absorbs and retains excess exudate to maintain a moist wound environment to support the healing process.3,4,5,6,7,8 AQUACEL Ag Advantage dressings have been developed to maximize the antimicrobial action of ionic silver, which has been shown in vitro to kill a broad spectrum of bacteria within the dressing, including antibiotic resistant superbugs.1 The unique Advantage formulation contains ethylenediaminetetraacetic acid (EDTA) and benzethonium chloride (BeCl), two agents that enhance performance by providing more rapid and sustained antimicrobial activity within the dressing, as compared with AQUACEL Ag Extra dressing (without the Advantage Technology) and demonstrated in vitro.1
In an international clinical evaluation study of over 100 patients, the Advantage Technology in combination with Hydrofiber Technology showed positive results in hard-to-heal wounds.2 In the study, supported by ConvaTec and published in the Journal of Wound Care, a single wound in each of 113 patients was observed over an average treatment period of 4.1 weeks. By the end of the study,
Most of the wounds studied presented as venous leg ulcers (52%) or diabetic foot ulcers (12%). The majority displayed clinical signs of infection and 74% had suspected wound biofilm, a known precursor to infection912 and a key cause of delayed healing10,11 as clinically determined by the evaluator. During the clinical evaluations, the only stipulated change in the protocol of care was the replacement of the previous primary dressing.
About ConvaTec ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions. The Company is listed on the London Stock Exchange (stock symbol: CTEC) and has leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits, including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. www.convatecgroup.com
*AQUACEL Ag Advantage dressing is marketed as AQUACEL Ag+ Extra dressing outside of the U.S. 8 AQUACEL and Hydrofiber are trademarks of ConvaTec Inc.